Anyone else notice that the quarterly report indicates that NVX is at stage 2 of the DOE loan application and have submitted application for technical AND financial viability but this stage is made up of two parts. Part one being technical eligibility and IF INVITED, part two is financial viability. So we have to assume they were invited to submit the second stage detailed application for financial viability review. Given NVX has been offered $150 million US grant by the same organisation (DOE) than we may assume that it is highly likely that a loan will be offered in due course.
- Forums
- ASX - By Stock
- 2023
Anyone else notice that the quarterly report indicates that NVX...
-
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NVX (ASX) to my watchlist
|
|||||
Last
70.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $347.1M |
Open | High | Low | Value | Volume |
70.5¢ | 72.5¢ | 70.0¢ | $206.6K | 290.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 20033 | 70.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.0¢ | 11867 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 25531 | 0.705 |
16 | 113328 | 0.700 |
9 | 106617 | 0.695 |
6 | 208332 | 0.690 |
5 | 27998 | 0.685 |
Price($) | Vol. | No. |
---|---|---|
0.710 | 11867 | 8 |
0.715 | 28039 | 41 |
0.720 | 25703 | 5 |
0.725 | 14098 | 5 |
0.730 | 33670 | 5 |
Last trade - 14.11pm 03/07/2024 (20 minute delay) ? |
Featured News
NVX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online